BioUtah, the trade association representing Utah's life sciences industry, has opened early bird registration for the 2026 Utah Life Sciences Summit, offering reduced pricing until October 11. The summit, presented by Mayer Brown, is scheduled for November 11 at the Hilton Salt Lake City Center. The event is expected to draw professionals from across the state's life sciences sector, which includes medical device manufacturing, biotechnology, biopharmaceuticals, diagnostics, and research and testing. The early bird discount provides an incentive for attendees to register ahead of the general deadline, potentially increasing participation and engagement. For full details on the announcement, including downloadable images and bios, interested parties can click here.
A key highlight of the summit will be a keynote address and in-person town hall discussion with Dr. Michelle Tarver, Director of the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration. Dr. Tarver's participation signals the importance of regulatory dialogue between industry stakeholders and federal regulators, particularly as medical device and diagnostic companies navigate evolving compliance landscapes. Her town hall format allows for direct interaction, which could provide valuable insights into FDA priorities and expectations. The summit will also feature topic-specific tracks covering workforce development, regulatory affairs, legal issues, and artificial intelligence, reflecting the multifaceted challenges and opportunities facing the life sciences sector.
The event comes at a time when Utah's life sciences industry is recognized as a key driver of the state's economy and a contributor to advancing healthcare. By convening industry leaders, regulators, and service providers, the summit aims to foster collaboration and innovation. The inclusion of AI as a track topic underscores the growing role of technology in life sciences, from drug discovery to patient care. Workforce and legal sessions address practical concerns that companies face in scaling operations and maintaining compliance. For BioUtah, a 501(c)(6) trade association, the summit represents a flagship effort to support its members and promote the state's ecosystem. More information about the association is available at BioUtah.
The early bird discount deadline of October 11 gives prospective attendees a limited window to secure reduced rates. As the life sciences industry continues to evolve, events like the Utah Life Sciences Summit provide critical forums for knowledge exchange and networking. The presence of a high-ranking FDA official like Dr. Tarver may attract significant interest, potentially boosting attendance and elevating the summit's profile. For companies in the sector, the opportunity to engage directly with regulators and peers could inform strategic decisions and partnerships. With the event just weeks away, stakeholders are encouraged to register promptly to take advantage of the savings and ensure their place at the Hilton Salt Lake City Center on November 11.
